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Western and Dot Immunoblotting Analysis of Viral 
Antigens and Antibodies: Application to Murine 
Hepatitis Virus 
Pierre J. Talbot 1, Robert L. Knobler and Michael J. Buchmeier 2 
Department of Immunology ( IMM 15), Scripps Clinic and Research Foundation, 10666 North Torrev Pines 
Road, La Jolla, CA 92037, U.S.A. 
(Received 2 April 1984, accepted 7 June 1984) 
Viral proteins were separated by sodium dodecyl sulfate polyacrylamide g l electrophoresis (SDS- 
PAGE) and transferred quantitatively to nitrocellulose by electroblotting in SDS-containing buffer. 
Monoclonal antibodies directed against previously defined epitopes on the viral proteins were used as 
probes to detect viral protein synthesis and processing, as well as expression i animal tissues. Circulating 
polyclonal antibodies were also probed and characterized for their polypeptide specificities. Under 
appropriate conditions, this Western immunoblotting technique was quantitative. Finally, a highly 
sensitive dot immunoblotting assay was used to analyze the sensitivity to denaturation f various epitopes 
on the viral proteins. This assay detected picogram quantities of viral antigens and antibodies. 
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Introduction 
The detection and characterization of trace amounts of specific proteins in 
biological materials has been facilitated by the use of specific polyclonal antisera 
and recently monoclonal hybridoma antibodies. Immunoprecipitation of in vitro 
radiolabeled cell extracts has been the method of choice for such detection and 
characterization. However, coprecipitation of unrelated proteins and proteolytic 
degradation of antigens during incubation can frequently lead to erroneous conclu- 
1 Work performed uring a postdoctoral fellowship at Scripps Clinic and Research Foundation. Current 
address: Virology Research Center, Institut Armand-Frappier, 531 Boul. des Prairies, C.P. 100, succ. 
L-D-R, Ville de Laval, Quebec H7N 4Z3, Canada. 
2 To whom correspondence should be addressed. 
Abbreoiations: SDS-PAGE, sodium dodecyl sulfate polyacrylamide g l electrophoresis; MHV-4, JHM 
strain of murine hepatitis virus-4; DBM, diazobenzyloxymethyl; N, nucleocapsid; Mr, relativemolecular 
weight; CPE, cytopathic effect; PBS, Dulbecco's phosphate-buffered saline, pH 7.4; MAb, monoclonal 
antibodies; PFU, plaque-forming units; LDs0, lethal dose for 50% of animals; BSA, bovine serum 
albumin; m.o.i., multiplicity of infection; Ig, immunoglobulin; cpm, counts per min; NGS, normal goat 
serum; NP-40, Nonidet P40; EDTA, ethylene diamine tetraacetic acid; PMSF, phenyl methyl sulfonyl 
fluoride. 
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sions. Moreover, this method cannot be used effectively with non-precipitating 
antibodies or with poorly soluble antigens (Braun et al., 1983). To circumvent these 
problems, techniques imilar in principle to the nucleic acid blotting methods 
pioneered by Southern (1975), Alwine et al. (1977), and Thomas (1980) were recently 
adapted to proteins. Initial separation by SDS-PAGE is followed by electrophoretic 
transfer of the proteins from the gel matrix onto a nitrocellulose or DBM-derivatized 
filter paper, producing a replica or blot of the original gel. Fractionated proteins 
blotted in this manner are accessible to specific antibodies. 
Renart et al. (1979) first reported the transfer of proteins by diffusion from 
polyacrylamide-agarose composite gels and their covalent coupling to DBM paper. 
Bowen et al. (1980) demonstrated that more convenient nitrocellulose supports could 
be used effectively with this passive diffusion technique. Rapid electrophoretic 
transfer to nitrocellulose or DBM paper was described by Towbin et al. (1979) and 
Symington et al. (1981). Transfer of proteins from SDS-PAGE gels was quantitative 
after long transfer times of 20-22 h at 6-8 V /cm (Burnette, 1981) or in the presence 
of SDS in the transfer buffer (Erickson et al., 1982). Transfer was a function of 
molecular weight; the largest proteins were transferred more slowly. Blots were 
shown to be re-usable after removal of the bound antibody probes (Renart et al., 
1979; Legocki and Verma, 1981; Symington et al., 1981; Erickson et al., 1982). 
The murine hepatitis viruses are coronaviruses which are causative agents of such 
diverse diseases as upper respiratory infection, gastroenteritis, hepatitis, encepha- 
lomyelitis and demyelination i colonized mice (Siddell et al., 1983). The MHV-4 
( JHM strain) isolate is of interest because it induces central nervous system de- 
myelinating disease (Weiner, 1973; Knobler et al., 1981, 1982; Stohlman and 
Weiner, 1981; Buchmeier et al., 1984). 
The virion contains a single-stranded RNA genome of positive polarity com- 
plexed with a nucleocapsid (N) protein of M r 56,000 (56 K) and 2 envelope 
glycoproteins E1 and E2 (M r = 23 K and 25 K for El; 100 K and around 200 K for 
E2) (Siddell et al., 1982; Sturman and Holmes, 1983). We have produced mono- 
clonal antibodies in this laboratory against he MHV-4 structural proteins and used 
these in structural and biological studies of the virus (Collins et al., 1982; Buchmeier 
et al., 1984; Talbot et al., 1984). In the course of these studies, we have explored the 
sensitivity of the Western immunoblotting technique for detection of viral antigens. 
We now report application of this method for the detection and characterization f 
viral antigens and antibodies in vitro and in vivo. We describe conditions under 
which it was possible to use this immunoblotting technique quantitatively. Moreover, 
we describe the use of a highly sensitive dot immunoblotting assay for analysis of the 
stability to denaturation of various epitopes recognized in the viral proteins by our 
panel of monoclonal antibodies. 
Materials and Methods 
Virus, cell culture and antigen preparation 
Murine hepatitis virus, strain JHM (MHV-4) is routinely propagated and assayed 
in our laboratory as previously described (Collins et al., 1982). To serve as a source 
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of viral antigen for Western immunoblotting assays, cells were infected with MHV-4 
at an m.o.i, of 1 until extensive CPE was observed (14-15 h) or for various 
incubation times as indicated. Infected and uninfected control cultures of 2 x 10 7 
cells were washed with rinse buffer (20 mM Tris-HCl, pH 9.0; 137 mM NaC1; 1 mM 
CaC12 and 0.5 mM MgC12) and solubilized for 20 min in 3 ml ice-cold lysis buffer 
(rinse buffer with 1% (v/v) NP-40, 10% (v/v) glycerol and 1% (v/v) aprotinin. Cell 
debris was pelleted at 1000 x g for 10 min and cytosols obtained after centrifugation 
at 100,000 x g for 60 min. 
Antigen preparations for dot immunoblotting assays consisted of a microsomal 
fraction from MHV-4 infected or uninfected control cells, as described previously 
(Talbot et al., 1984). Native antigen was used as a suspension in PBS or after 
treatment at 37°C for 20 min with a final concentration of 2% (v/v) NP-40 in 10 
mM Tris-HC1, pH 7.4, 0.2 M NaC1, 0.5 M KC1, 2 mM EDTA, 1 mM PMSF and 1% 
(v/v) aprotinin. Denatured antigen was prepared by boiling for 2 min in an 
SDS-containing sample buffer for SDS-PAGE (Laemmli, 1970). Protein concentra- 
tions were determined (Lowry et al., 1951) using BSA as a standard. 
Mice sera and brain homogenates 
Four- to 5-week-old BALB/c mice were obtained from our institutional breeding 
colony. Sera were obtained by bleeding from the retroorbital plexus of ether- 
anesthetized animals. Acutely infected mice were obtained after intracerebral inocu- 
lation of 3 PFU (10-30 LDs0 ) of MHV-4. Three days after infection, when virus 
titers in the brain were high (1-2 x 105 PFU per gram of brain), mice were 
sacrificed, their brains removed and a 10% (w/v) homogenate prepared in PBS. 
Homogenates were clarified by centrifugation at 700 x g for 10 rain. 
Monoclonal antibodies to MHV-4 
A library of monoclonal antibodies to the structural proteins of MHV-4 was 
raised and characterized as described elsewhere (Collins et al., 1982; Buchmeier et 
al., 1984; Talbot et al., 1984). 
Electrophoresis 
Proteins obtained from cytosol extracts of infected and control L-24 cells, or from 
infected and control mouse brain homogenates were boiled in the presence of 2% 
(v/v) 2-mercaptoethanol for 2 min in SDS-PAGE sample buffer and separated on 
10.5% acrylamide separating els (Laemmli, 1970). Each separating el lane (6 x 80 
x 1.5 ram) received either 8.5-51 fig of total cytosol proteins or the equivalent of 
750 #g wet weight of brain tissue. Gels were electrophoresed for 2-3 h at 150 V. 
Western immunoblotting 
Gel replicas were prepared by electrophoretic transfer to nitrocellulose sheets 
(0.45 /zm pore size, Schleicher and Schuell, Keene, NH) using a Trans-Blot cell 
(Bio-Rad Laboratories, Richmond, CA). The electrophoretic transfer method of 
Towbin et al. (1979) was used with the following modifications. SDS (0.1% (w/v)) 
was added to the transfer buffer in order to achieve quantitative protein transfer 
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(Erickson et al., 1982). We found that a 3 h transfer at 5 V /cm was sufficient for 
quantitative transfer of the MHV-4 N protein (M r = 56 K), whereas 6 h were 
required for complete transfer of proteins of M r higher than about 100-150 K, such 
as the E2 glycoprotein. Proteins transferred to nitrocellulose sheets were stained as 
described (Towbin et al., 1979), then destained in distilled water. If necessary, the 
nitrocellulose sheets were stored overnight at 4°C in 3% (w/v) BSA) in PBS with 1% 
(v/v)  NGS. 
Nitrocellulose strips in plastic 15 ml conical tubes were saturated by incubation 
with constant shaking for 60 rain at 37°C with 8 ml of blocking buffer (3% (w/v) 
BSA in PBS containing 0.5% (v/v) NP-40, 0.1% (w/v) sodium deoxycholate and 1% 
(v/v)  NGS). To probe for viral antigen, strips were then incubated for 3 h at 37 o C 
with either 400-fold dilution of mouse sera or hybridoma cell culture supernatants 
diluted 2-4-fold with blocking buffer. In 1 experiment, various amounts (5-500-fold 
dilutions) of supernatants containing MAb 4B6.2 were added (46 /~g-4.6 ng anti- 
body, as determined by radial immunodiffusion against sheep anti-mouse IgG). 
Strips were washed (3 times, 10 rain) in PBS with 0.05% (v/v) Tween 20 and bound 
antibodies were detected by incubation for 1-1.5 h at 37°C with 125I-labeled, 
affinity purified goat antibody to mouse Ig (Buchmeier et al., 1984; specific activity 
3-5/~Ci//~g; 0.5-1 x 10 6 cpm per gel lane) diluted in 8 ml of blocking buffer. The 
strips were again washed, extensively dried at room temperature and autoradio- 
graphed for 6-48 h at -70  ° C with an intensifying screen. In 1 experiment, bound 
radioiodinated antibodies were quantitated by counting portions of nitrocellulose 
strips containing N protein and scanning corresponding exposed X-ray films at 550 
nm in a spectrophotometer. We routinely use radioiodinated, affinity purified goat 
anti-mouse Ig for our immunoblotting studies because we find this probe to be much 
more sensitive for detecting mouse lg than radiolabeled protein A. 
Dot immunoblotting 
Either native or denatured viral or control antigen (19-2400 ng total protein) 
prepared as described above was spotted onto nitrocellulose strips n a volume of 3.5 
#1. The strips were dried under a heat lamp for 10 min, saturated in blocking buffer 
and probed with 2-400-fold dilutions of various hybridoma supernatants, as de- 
scribed for Western immunoblotting, except that incubations with antibody were 
reduced to 1 h each. In 1 experiment, various amounts (2-48,600-fold ilutions) of 
supernatants containing MAb 5B188.2 were added (40 /~g to 1.6 ng antibody, as 
determined by radial immunodiffusion against sheep anti-mouse IgG). 
Results and Discussion 
Detection of viral antigens 
(1) Antigenic analysis of viral epitopes 
Immunoprecipitation of glycoproteins from solution may yield ambiguous results 
due to coprecipitation, or poor antigen solubility. These shortcomings and ambigui- 
ties were largely eliminated by the immunoblotting technique (Talbot et al., 1984). 
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Polypeptide specificity of different MAb can be clearly determined, providing the 
antibody can still recognize its target epitope after protein denaturation. All 5 of our 
MAb to the N protein and more than half (7 out of 13) of the antibodies to the viral 
glycoproteins bound well to the denatured protein (Talbot et al., 1984). Other MAb 
appeared to recognize a conformation-dependent structure which was lost upon 
antigen preparation for Western immunoblotting. For these antibodies, im- 
munoprecipitation had to be utilized. In order to further analyze this postulated 
sensitivity to denaturing agents such as SDS of some viral epitopes, we used a 
convenient and highly sensitive dot immunoblotting assay (Hawkes et al., 1982; 
Herbrink et al., 1982). 
As shown in Fig. 1, all 18 of our monoclonal antibodies to the MHV-4 structural 
proteins specifically recognized the native viral antigen even when treated with the 
non-ionic detergent NP-40. However, upon denaturation by boiling in SDS and 
2-mercaptoethanol, some of our MAb to the viral glycoproteins E2 and E1 lost 
reactivities (Fig. 1, lanes 3, 4, 8, 9, 11, 13: note absence of virus-specific binding) as 
predicted from their absence of binding on Western immunoblots (Talbot et al., 
1984). It is likely that the epitopes recognized by such antibodies are dependent on 
the secondary and tertiary structure of the protein. Antibody binding to such 
conformation-dependent structures thus requires preservation of the native structure 
of the protein, which can be achieved with the non-ionic detergent NP-40. It is 
unclear why 3 MAb to the N protein lost their reactivities on the SDS-treated 
antigen (Fig. 1, lanes 15, 16, 17) by dot immunoblotting but reacted on Western 
immunoblots (Talbot et al., 1984). 
The excluisite sensitivity of the dot immunoblotting assay is evident in Fig. 2. In 
panel A, we show that using an excess of antibody, as little as 38 ng of membrane- 
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Fig. 1. Dot immunoblotting analysis of binding of monoclonal antibodies to MHV-4 structural proteins 
(E2, El, N) in their native (PBS, NP-40) or denatured (SDS) state. Microsomal proteins (2.4 p~g in 3.5 ~1) 
from infected (MHV-4) or uninfected (control) cells were applied as a dot to nitrocellulose strips and 
probed with a previously determined optimal amount of hybridoma cell culture supernatant (lanes 1, 2, 7, 
18:10 p,1; lane 4:20 ~1; lanes 5, 6, 10, 12:1 ml; lanes 3, 8, 9, 11, 14, 17:2 ml; lanes 13, 15, 16:3 ml, in a 
total of 4 ml blocking buffer) and radioiodinated antibodies to mouse Ig, as described in the text. The 
hybridoma designations are as follows: 1, 5B19.2; 2, 5B170.3; 3, 5A13.5; 4, 4Bll.6; 5, 5B21.5: 6, 5B93.7; 
7, 5B207.3; 8, 5B216.8; 9, 5Bll.5; 10, 5A5.2; 11, 5Bl19.6; 12, 5B128.3; 13, 5B39.1; 14, 4B6.2; 15, 
5B145.5; 16, 5B175.5; 17, 5B86.2; 18, 5B188.2. 
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enriched fraction from infected cells is sufficient for the detection of the MHV-4 N 
protein. Coomassie blue staining of SDS-PAGE gels of such antigen preparations 
showed that they contained approximately 1% of N protein (data not shown). 
Therefore, 380 pg of N protein can be detected in such an assay, which thus 
compares favorably with radioimmunoassays (RIA) or enzyme immunoassays (EIA). 
Fig. 2B describes the sensitivity of this technique for the detection of specific viral 
antibodies. Using an excess of viral antigen, as little as 1.6 ng of MAb to the N 
protein can be detected, the equivalent of 82 nl of hybridoma cell supernatant. 
Specifically, a 48,600-fold ilution of this antibody still gave a specific signal; this 
compares advantageously to its end-point iter determined by EIA of 18,000 (data 
not shown). 
This dot immunoblotting assay should prove valuable in the screening of hy- 
bridomas for the secretion of virus-specific antibodies. In addition, the sensitivity of 
target epitopes to denaturation can be rapidly determined in order to predict which 
antibodies are likely to perform well on Western immunoblotting analyses. Other 
applications include the detection of viral antigens in cell or tissue extracts, as well 
as a simple monitoring assay during the purification of viral p~,oteins. We are 
currently using the dot immunoblotting assay to monitor the effluent from im- 
munoaffinity columns. 
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Fig. 2. Determination of the sensitivity of the dot immunoblotting assay for antigen (A) or antibody (B). 
Increasing amounts (19 ng-2.4 /xg) of NP-40 extracted microsomal proteins from infected (I) or 
uninfected control (C) cells were applied as 3.5 /~1 dots on a nitrocellulose strip which was then probed 
with an excess of MAb 5B188.2 to the MHV-4 nucleocapsid protein (40 t~g of IgG or a 4-fold dilution in 
a total of 8 ml blocking buffer) and radioiodinated antibodies to mouse Ig, as described in the text (A). 
Alternatively, antigen was applied as described in the legend of Fig. 1 and probed with decreasing 
amounts of MAb 5B188.2 (2-48,600-fold ilutions in 4 ml, with the corresponding amounts of IgG 
shown) and radioiodinated antibodies to mouse Ig, as described in the text (B). 
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Fig. 2B also i l lustrates a common problem encountered in Western immunoblot-  
ting: non-specif ic binding of ant ibody to control antigen. When native antigen was 
used for dot immunoblott ing,  this problem was negligible. However, denatured 
antigen showed significant background binding in condit ions of excess ant ibody 
(0.1-40 t~g). The background binding was el iminated when a l imiting amount of 
ant ibody was used (less than 0.1 ~g in this case). Therefore, background problems 
on Western immunoblots  hould likely be significantly reduced by optimizing the 
immunobinding condit ions of the assay. 
(2) Quantitation of antigens 
In the course of our studies, we were interested to determine if the Western 
immunoblott ing technique could be used for quantitat ion of viral antigens in 
infected cells or tissues. Using MAb 4B6.2 against the N protein as a probe, we 
performed the experiment i l lustrated in Fig. 3. In this experiment, a l inear dose 
response of ant ibody binding was observed when an excess of ant ibody was used to 
detect l imiting amounts of viral antigen in infected cell lysates which contained 
approximately 1% of N protein as shown by Coomassie blue staining of SDS-PAGE 
gels of such lysates (Fig. 3A). It was also possible to demonstrate saturat ion of viral 
antigen with increasing amounts of ant ibody (Fig. 3B). Thus, within these l imits we 
have defined the technique could be used in a quantitative manner for studies on the 
expression of viral antigens without the need for radiolabeling. 
(3) Time course of protein synthesis and processing 
Another  appl icat ion of this immunoblott ing procedure was the analysis of viral 
protein synthesis and processing, as i l lustrated in Figs. 4 and 5. The intracel lular 
i 1,0 
- -  I 
0.6 "g 
0.4 
0.2 ~ 
10 20 30 40 50 O 1 2 3 4 
#g Total Protein #g Nucleocapsid Antibody 
Fig. 3. Quantitative detection of MHV-4 nucleocapsid protein by Western immunoblotting. Different 
amounts (A) or a constant amount of 51 /Lg (B) of cytosol proteins from infected cells were separated by 
SDS-PAGE, transferred to nitrocellulose and probed with increasing amounts (B) or an excess (A) of 
MAb 4B6.2 against the N protein, as described in the text. The binding of radioiodinated antibodies 
against mouse Ig to MAb 4B6.2 was quantitated by cutting out the areas containing bands and 
gamma-counting of nitrocellulose ( . . . . . .  ) or scanning of corresponding darkened X-ray film ( ) 
exposed for 18 (O) or 36 (0) h at -70 o C with an intensifying screen. 
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accumulation of viral proteins in L-24 cells infected with MHV-4 at an m.o.i, of 1 
was detected by Western immunoblotting. 
As shown in Fig. 4, the MHV-4 N protein was detected in infected cells as early 
as 8 h after infection, 2 h prior to release of progeny virions (data not shown). It was 
synthesized in the form of a 56 K polypeptide which accumulated up to 14 h after 
infection. Thereafter, the total amount of this 56 K protein gradually decreased, 
concomitant with the appearance of a smaller 50 K polypeptide. Since the 2 
polypeptides were recognized by the same MAb and appear in a well-defined 
temporal order, they likely constitute 2 forms of the N protein, the 50 K molecule 
being likely derived by proteolytic cleavage from the 56 K, as was suggested 
previously (Anderson et al., 1979). Progeny virions appear to contain exclusively the 
56 K polypeptide (data not shown), which makes the significance of the intracellular 
50 K protein unclear. 
In a similar manner, the time course of appearance of the viral glycoproteins 
could be analyzed as shown in Fig. 5. The glycoprotein E2 was first detected at 
10-12 h after infection (Fig. 5A) as high molecular weight aggregates which did not 
penetrate separating els. Thereafter, there was a gradual increase in a polypeptide 
of M r approximately 200 K. Cleavage of this 200 K molecule into two 100 K 
subunits has been associated with acquisition of cell fusion activity (Sturman and 
Holmes, 1984). In addition, an approximately 150 K intracellular precursor to the 
o- 
94- 
-~ 67- 
~= 43- 
30- 
N 2~ 
d. 
N 4 
g 3 
~ 2- 
.~ 1- 
8 10 12 14 16 18 20 
Time After Infection (hr) 
Fig. 4. Time course of appearance of MHV-4 nucleocapsid polypeptides detected by Western immuno- 
blotting. L-24 cells were infected with MHV-4 at an m.o.i, of 1 for various times, and polypeptides 
reacting with MAb 4B6.2 to N protein detected by Western immunoblotting, as described in the text. 
Blots shown in A were scanned at 550 nm from the origin (o) to the dye front (d) to quantitate the 
appearance of the 56 and 50 K polypeptides, as illustrated in B. The migration of molecular weight 
markers is shown on the left of A. 
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structural glycoprotein E2 (Siddell et al., 1981; Talbot et al., 1984) was transiently 
detected at 14 and 16 h after infection, but not later on (Fig. 5A, arrow), suggesting 
a precursor-product relationship. In our hands, the 100 K monomeric form of E2 
was not detected in this experiment even at late times after infection when extensive 
cell-cell fusion was evident. 
The small glycoprotein E1 was initially detected at around 10 h after infection in 
an unglycosylated 23 K form (Fig. 5B). Thereafter, a gradual increase in the 
glycosylated 25 K form of the molecule was apparent.  Both forms of the protein are 
incorporated into progeny virions (Wege et al., 1979; data not shown). 
These studies emphasize the usefulness of this immunoblott ing technique as a 
complement o pulse and pulse-chase radiolabeling. Although it is aimed at the 
detection of accumulated protein precursors and their processed products, our work 
clearly demonstrates that it can identify precursor-product relationships and that the 
use of MAb minimizes ambiguities. Moreover, this technique l iminates the need for 
radiolabel ing the proteins of interest. It should prove especially invaluable in studies 
when these proteins constitute only a very small proport ion of the total protein 
content of the sample, such as the synthesis of viral protein when cellular protein 
synthesis is only inefficiently or not at all turned off by the infection, or the 
detection of viral proteins in infected tissues. 
A B 
116k - -  
97.4k - -  
66k - -  
45k - -  
29k - -  
20k - -  
0 2 4 6 8 10 12 14 16 18 0 4 6 8 10 12 14 16 
Hours After Infection 
Fig. 5. Time course of appearance of MHV-4 glycoproteins detected by Western immunoblotting. L-24 
cells were infected with MHV-4 at an m.o.i, of 1 for various times, and polypeptides r acting with either 
MAb 5B19.2 to the E2 glycoprotein (A) or 5A5.2 to the E1 glycoprotein (B) detected by Western 
immunoblotting, as described in the text. The migration of molecular weight markers is shown on the left. 
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(4) Detection of viral antigens in animal tissues 
The Western immunoblotting technique has been used successfully to detect the 
expression of viral antigens in the brains of infected animals (Fig. 6). We prepared 
homogenates of brain tissue from MHV-4 infected mice and using MAb 4B6.2, we 
could detect both the 56 K and 50 K forms of the N protein (Fig. 6, lane 3), which 
constituted a minor proportion of total protein. By comparison with a standard 
curve such as shown in Fig. 3A, we estimated that the brain sample analyzed in such 
a way contained approximately 150 ng of the 56 K polypeptide and 250 ng of the 50 
K molecule (in 0.75 mg wet weight of brain tissue). These values represent 0.02 and 
0.03% of total brain weight, respectively. 
We have failed so far to detect he E1 glycoprotein in acutely infected brain tissue 
(Fig. 6, lane 2). On the other hand, the E2 glycoprotein was detected as a faint 200 K 
band (Fig. 6, arrow). 
Detection of antiviral antibodies 
In addition to the use of Western immunoblotting to identify and quantitate viral 
antigens in cells and tissues, we have also found this technique to be a sensitive 
means of detecting antiviral antibodies in animals and etermining their polypeptide 
specificity. Murine coronaviruses are frequently enzootic in colonized mice. In this 
study, mice were screened prior to experimental infection for preoexisting antibodies 
116k  - -  
97 .4k  - -  
66k  - -  
45k  - -  
29k  - -  
20k - -  
1 2 3 4 
Fig. 6. Detection of MHV-4 polypeptides in mouse brain by Western immunoblotting. Mice were infected 
with MHV-4 and brain homogenates prepared 3 days later as described in the text. Nitrocellulose replicas 
of SDS-PAGE separated tissue proteins were probed with MAb 5B19.2 to the viral E2 glycoprotein (lane 
1), 5A5.2 to the E1 glycoprotein (lane 2) or 4B6.2 to the N protein (lanes 3 and 4). Lane 4 contains tissue 
proteins from uninfected, MHV-4 seronegative mice. Note the presence of a 200 K polypeptide in lane 1 
(arrow) and both 56 and 50 K polypeptides in lane 3. The migration of molecular weight markers is 
shown on the left. 
1 2 
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Fig. 7. Detection of antibody to MHV-4 in the serum ofBALB/c mice by Western immunoblotting. Nine 
individual mice were ye-bled and 400-fold dilutions of their sera reacted with SDS-PAGE separated 
proteins from cytosol extracts of MHV-4 infected (I) or control uninfected (C) L-24 cells, as described in 
the text. The migration of molecular weight markers is shown on the left. Note the binding to a 56 K viral 
polypeptide. 
to an antigenically related murine coronavirus. As shown in Fig. 7, we frequently 
found antibodies to a viral protein of approximately 56 K, presumably the N 
protein. Ant ibodies to MHV glycoproteins were not detected, either because of a low 
titer or failure to cross-react with the MHV-4 strain used as antigen. This technique 
offers the advantage of simultaneous determinat ion of both presence and poly- 
peptide specificity of antibodies. 
Concluding Remarks 
Western immunoblott ing is a convenient, sensitive and specific technique for the 
detection of antigens and antibodies. It has been used mainly for the determinat ion 
of polypept ide specificity of monoclonal  antibodies. In the present study, we have 
appl ied this technique to the analysis of viral protein synthesis and processing, 
expression of viral proteins in animal tissues and characterization of circulating 
antiviral antibodies. Under  appropr iate conditions, quantitative analyses could be 
performed. We have also shown that a dot immunoblott ing assay can be a very 
sensitive means for the detection of viral antigens and antibodies, as well as the 
antigenic analysis of viral proteins. 
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